Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

A Prospective, Comparative Study of Intravenous Iron Isomaltoside 1000 (Monofer®) Administered by Infusions to Non-Anaemic Patients Undergoing Elective or Sub-Acute Coronary Artery Bypass Graft, Valve Replacement or a Combination Thereof (CABG-01)

This study has been completed.
CRO Max Neeman
Information provided by (Responsible Party):
Pharmacosmos A/S Identifier:
First received: March 16, 2012
Last updated: April 28, 2014
Last verified: April 2014
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: September 2013
  Primary Completion Date: August 2013 (Final data collection date for primary outcome measure)